Novartis AG (NVS) is a publicly traded Healthcare sector company. As of September 4, 2026, NVS trades at $152.37 with a market cap of $309.99B and a P/E ratio of 0.00. NVS moved -1.90% today. Year to date, NVS is +16.01%; over the trailing twelve months it is +23.33%. Its 52-week range spans $97.39 to $170.46. Analyst consensus is neutral with an average price target of $159.00. Rallies surfaces NVS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
5 analysts cover NVS: 0 strong buy, 2 buy, 2 hold, 1 sell, and 0 strong sell. The consensus rating is neutral. The average price target is $159.00.
| Metric | Value |
|---|---|
| Price | $152.37 |
| Market Cap | $309.99B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 4.74% |
| 52-Week High | $170.46 |
| 52-Week Low | $97.39 |
| Volume | 1.08M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
5 analysts cover NVS: 0 strong buy, 2 buy, 2 hold, 1 sell, 0 strong sell. Consensus rating is neutral. Average price target: $159.00.